Abstract | CONTEXT: OBJECTIVE: DESIGN AND SETTING: We used PCR to analyze the SLC34A3 gene in the proband and members of his family. RESULTS: The proband was a compound heterozygote for two SLC34A3 missense mutations, a novel c.544C-->T in exon 6 that results in replacement of arginine at position 182 by tryptophan (R182W) and c.575C-->T in exon 7 that results in replacement of serine at position 192 by leucine (S192L). The R182W and S192L alleles were inherited from the mother and father, respectively, both of whom had hypercalciuria. A clinically unaffected brother was heterozygous for S192L. CONCLUSION: We report a novel mutation in the SLC34A3 gene in a patient with an unusual presentation of HHRH. This report emphasizes that moderate and severe hypercalciuria can be manifestations of heterozygous or homozygous loss-of-function mutations in the SLC34A3 gene, respectively, providing further evidence for a gene dosage effect in determining the phenotype. HHRH may be an underdiagnosed condition that can masquerade as idiopathic hypercalciuria or osteopenia.
|
Authors | Amanda L Tencza, Shoji Ichikawa, Anna Dang, David Kenagy, Edward McCarthy, Michael J Econs, Michael A Levine |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 94
Issue 11
Pg. 4433-8
(Nov 2009)
ISSN: 1945-7197 [Electronic] United States |
PMID | 19820004
(Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- SLC34A3 protein, human
- Sodium-Phosphate Cotransporter Proteins, Type IIc
|
Topics |
- Child
- Exons
(genetics)
- Familial Hypophosphatemic Rickets
(genetics, pathology)
- Female
- Femur
(pathology)
- Heterozygote
- Humans
- Hypercalciuria
(genetics)
- Magnetic Resonance Imaging
- Male
- Mutation, Missense
- Nephrolithiasis
(genetics)
- Nuclear Family
- Polymerase Chain Reaction
- Sodium-Phosphate Cotransporter Proteins, Type IIc
(genetics)
- Tibia
(pathology)
|